Wharton Commencement Speaker to Share How the MBA Could Save His Life
The following post has been republished in its entirety from original source clearadmit.com.
David Fajgenbaum, MD, MSc, has been working toward his MBA as if his life depends on it. Because it does. On Sunday, in his commencement address to his classmates at the University of Pennsylvania’s Wharton School, he will share just why he believes a graduate management education can be the difference between life and death.
Fajgenbaum was diagnosed with idiopathic Multicentric Castleman disease (iMCD) in 2010, a rare and poorly understood hematologic disorder in which the immune system becomes activated and causes cells to release inflammatory proteins that ultimately shut down the body’s organs. At the time of his diagnosis, he was in his third year of medical school at the University of Pennsylvania’s Perelman School of Medicine. He took a year’s leave and underwent aggressive chemotherapy, which initially was unsuccessful. Over a six-month period, he was hospitalized for four and a half months and even read his last rites. But ultimately the chemo helped put the disease into remission, and Fajgenbaum returned to complete his MD. He then proceeded straight into the MBA program at Wharton. Continue reading…
